Gaudium IVF and Women Health Limited

NSE: GAUDIUMIVF

28

total announcements

GAUDIUMIVF.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 17 Oct 2026

Market Cap

₹738 Cr

P/E (TTM)

30.0

EPS (TTM)

₹3.38

52W Low

₹69.18

52W High

₹163.18

Dividend Yield

0.00%

Price / Book

4.2

Debt / Equity

16.1

Revenue (TTM)

₹106 Cr

Gross Margin

51.38%

Operating Margin

8.79%

NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults11 Aug 2026

Gaudium IVF and Women Health Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Gaudium IVF and Women Health Limited has informed the Exchange about the schedule of a meet to discuss the Q1 FY27 earnings, to be held on August 14, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveExpansion16 Jul 2026

Gaudium IVF and Women Health Limited

Press Release

Gaudium IVF and Women Health Limited, India's first listed IVF company, has launched its first milestone in a planned 19-centre expansion, unveiling its AI-powered Signature Labs in South Delhi. The new centre combines AI-assisted embryology, globally benchmarked laboratory standards, and 17 years of fertility experience to provide high-quality, technology-driven fertility care to aspiring parents.

Read more →📎 1 attachment
NSECommencement of commercial production/operations▲ PositiveExpansion15 Jul 2026

Gaudium IVF and Women Health Limited

Commencement of commercial production/operations

Gaudium IVF and Women Health Limited has informed the Exchange about the commencement of commercial operations at its new IVF Centre/Hub at South Extension, New Delhi, with effect from July 16, 2026.

Read more →📎 1 attachment
NSECertificate under SEBI (Depositories and Participants) Regulations, 201811 Jul 2026

Gaudium IVF and Women Health Limited

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Gaudium IVF and Women Health Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, stating that the regulation is not applicable to the company as all shares are in demat form and no requests for rematerialisation or dematerialization were received during the quarter.

Read more →📎 1 attachment
NSETrading WindowResults26 Jun 2026

Gaudium IVF and Women Health Limited

Trading Window

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.

Read more →📎 1 attachment
NSEUpdatesResults25 Jun 2026

Gaudium IVF and Women Health Limited

Updates

Gaudium IVF and Women Health Limited has submitted a corrigendum to its financial results for the quarter and year ended March 31, 2026, correcting inadvertent regrouping and typographical errors in the comparative figures for the previous financial year ended March 31, 2025.

Read more →📎 1 attachment
NSEOutcome of Board MeetingExpansion25 Jun 2026

Gaudium IVF and Women Health Limited

Outcome of Board Meeting

Gaudium IVF and Women Health Limited has informed the Exchange regarding Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital At Lucknow, Uttar Pradesh. The Board of Directors approved the proposal for establishment, development, operation and management of "Gaudium Women Hospital, Lucknow" at the property situated in Lucknow, Uttar Pradesh, through a long-term arrangement with the owner of the said property.

Read more →📎 1 attachment
NSEDisclosure under SEBI Takeover Regulations▲ PositivePledge22 Jun 2026

Gaudium IVF and Women Health Limited

Disclosure under SEBI Takeover Regulations

Dr. Manika Khanna, a promoter of Gaudium IVF and Women Health Limited, has submitted a disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the Promoter and Promoter Group did not create any encumbrances (pledges) on the company's shares, either directly or indirectly, during the financial year ended March 31, 2026. This annual declaration reassures stakeholders regarding the stability of promoter shareholding.

Read more →📎 1 attachment
← PreviousPage 2 of 2